Literature DB >> 31980497

Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin.

Simone H J van den Elsen1, Onno W Akkerman2,3, Erwin M Jongedijk1, Mireille Wessels1, Samiksha Ghimire1, Tjip S van der Werf3,4, Daan J Touw1, Mathieu S Bolhuis1, Jan-Willem C Alffenaar5,6,7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31980497     DOI： 10.1183/13993003.01903-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment.

Authors:  Hannah Yejin Kim; Shashikant Srivastava; Hemanth Kumar Ak; Ben J Marais; Jan-Willem Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.

Authors:  Jan-Willem C Alffenaar; Erwin M Jongedijk; Claudia A J van Winkel; Margaretha Sariko; Scott K Heysell; Stellah Mpagama; Daan J Touw
Journal:  J Antimicrob Chemother       Date:  2021-01-19       Impact factor: 5.790

3.  Clinical Value of Emerging Bioanalytical Methods for Drug Measurements: A Scoping Review of Their Applicability for Medication Adherence and Therapeutic Drug Monitoring.

Authors:  Tanja R Zijp; Zamrotul Izzah; Daan J Touw; Job F M van Boven; Christoffer Åberg; C Tji Gan; Stephan J L Bakker
Journal:  Drugs       Date:  2021-11-01       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.